CureVac
German bio-pharmaceutical company
CureVac ▸ Facts ▸ Comments ▸ News ▸ Videos
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee. CureVac had approximately 240 employees in November 2015 and 375 in May 2018.
0 shares | ShareTweetSavePostSend |
You Might Like
No news matches foundSorry, we were unable to find any results in our database for your queryFree news archive accessDid you know? You are eligible to search our news archive with millions of news references free of charge. To do this, please sign in first at the top of the screen. • Information about free access to our news archive Search this site and the web: |